Hikma Pharmaceuticals (HIKL)

1,824.00p
   
  • Change Today:
    -0.15p
  • 52 Week High: 2,348.00
  • 52 Week Low: 1,595.50
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 72,316
  • Market Cap: £3,636.78m

Financial Analysis

Select chart: EPS | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue ($m) Pre-tax ($m) EPS Dividend
30-Jun-25 Interim 1,658.00 295.00 122.00¢ 36.00¢

Key Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 2,341.00 558.00 172.90¢ 19.5 1.3 +15% 50.00¢ 1.5%
31-Dec-21 2,553.00 544.00 194.80¢ 15.2 1.2 +13% 54.00¢ 1.8%
31-Dec-22 2,517.00 233.00 181.00¢ 11.5 n/a -7% 56.00¢ 2.7%
31-Dec-23 2,875.00 281.00 223.00¢ 10.7 0.5 +23% 72.00¢ 3.0%
31-Dec-24 3,127.00 455.00 224.00¢ 12.0 n/a 0% 80.00¢ 3.0%

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 19.91 10.14 13.39 0.76

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

HIKL Market Data

Currency UK Pounds
Share Price 1,824.00p
Change Today -0.15p
% Change -0.82 %
52 Week High 2,348.00
52 Week Low 1,595.50
Volume 72,316
Shares Issued 199.39m
Market Cap £3,636.78m

Trades for 07-Oct-2025

Time Volume / Share Price
16:29 122 @ 1,824.00p
16:29 175 @ 1,824.00p
16:29 156 @ 1,824.00p
16:29 183 @ 1,824.00p
16:29 158 @ 1,824.00p

HIKL Key Personnel

CEO Riad Mishlawi

Top of Page